SEQENS is a global integrated CDMO and specialty ingredients leader with 15 production sites across 9 countries and 5 R&D centers. The company manufactures custom and generic APIs, intermediates, excipients, custom lipids for drug delivery (mRNA/siRNA, LNP), HPAPIs, and specialty chemicals. SEQENS also operates CELLforCURE, an EMA-authorized CDMO for Advanced Therapy Medicinal Products (ATMPs/Cell & Gene Therapy). The company serves 1,500+ customers in 80+ countries with approximately 2,700 employees and ~1B EUR revenue.
custom API synthesis, HPAPI manufacturing, lipid nanoparticle components (mRNA/siRNA), cell & gene therapy (CELLforCURE), flow chemistry, biocatalysis
5 sites worldwide
No reviews available yet.
No documents available.